Tenaya Therapeutics up as heart disorder drug gets 'orphan' designation

Tenaya Therapeutics

28/11/2022 14:25

** Shares of drug developer Tenaya Therapeutics Inc  TNYA.O 
jump 4% to $2.6 premarket
    ** U.S. FDA grants orphan drug designation for TNYA's gene
therapy candidate to treat patients with rare heart disease,
arrhythmogenic right ventricular cardiomyopathy  urn:newsml:reuters.com:*:nGNX6nWMHl
    ** FDA awards "orphan" status to drugs that treat rare
conditions and are protected through a series of government
incentives once they reach the market
    ** As of Friday's close, company's shares down ~87% YTD
 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com))